Circulating Tumour Cells

 

 

As part of ESMO's continuous commitment to offering beneficial educational material relevant to your work and practice in order to receive your certificate, please complete the Evaluation Survey, which will take approximately 5 minutes. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did your undertaking of this E-Learning module allow you to understand the role of circulating tumour cells (CTCs) and disseminating cancer cells (DCCs) in metastatic process? (1-not at all; 5-a lot)

2. Did your undertaking of this E-Learning module allow you to learn about basic techniques for CTCs and DCSs isolation, their molecular profile analysis, and predictive and prognostic characteristics? (1-not at all; 5-a lot)

3. Did your undertaking of this E-Learning module allow you to review most important reports regarding implementation of CTCs in biomarker studies and to correlate their molecular profiles with clinical data? (1-not at all; 5-a lot)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-completely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestions to improve future ESMO E-Learning material, please write in the box below: